NEO-Innovator

Neo-Pharma Biotech is an innovation-driven biotechnology company established in 2022 that specializes in the design and structural optimization of small molecule drugs. The company focuses on revitalizing off-patent therapeutics through precise functional group modifications and advanced chemical synthesis to develop novel drugs with enhanced clinical value. Its current pipeline includes broad-spectrum antivirals for respiratory infections, small molecules for neurodegenerative disorders like Huntington's disease, and novel compounds for pancreatic cancer. Neo-Pharma Biotech operates globally with a presence in Taiwan, Singapore, and the United States, bridging the gap between drug discovery and clinical application.